calendar
3,926 catalysts · 3,394 8k filing · 575 earnings · 172 phase 2 completion · 73 phase 1 completion · 62 phase 2 initiation · 40 phase 1 initiation
3,926 catalysts · 3,394 8k filing · 575 earnings · 172 phase 2 completion · 73 phase 1 completion · 62 phase 2 initiation · 40 phase 1 initiation
Items: 1.01, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 1.01, 5.08, 9.01
Items: 8.01, 9.01
Items: 5.02
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 8.01, 9.01
Items: 1.01, 2.03, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 5.07, 9.01
Items: 2.02, 9.01
Items: 4.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02, 9.01
Items: 5.03, 9.01
Items: 5.07, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 3.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 1.01, 7.01, 9.01
Items: 5.02
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01